Insmed Targets $5bn-Plus Market With Brinsupri For Bronchiectasis

First Approval For Disease And Drug Mechanism

 
• By Mandy Jackson
  
Brensocatib approvals for bronchiectasis are pending in the EU and UK (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip